# CardioSenseSystem Compared Study Regarding Efficacy and Safety in the Monitoring of ECG

> **NCT03610529** · NA · UNKNOWN · sponsor: **Novosense AB** · enrollment: 60 (estimated)

## Conditions studied

- Cardiac Arrythmias
- Unstable Angina
- Heart Valve Disorders
- Disorder of Aorta

## Interventions

- **DEVICE:** CardioSenseSystem
- **DEVICE:** Philips Intellivue

## Key facts

- **NCT ID:** NCT03610529
- **Lead sponsor:** Novosense AB
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-09
- **Primary completion:** 2020-12
- **Final completion:** 2020-12-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2020-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03610529

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03610529, "CardioSenseSystem Compared Study Regarding Efficacy and Safety in the Monitoring of ECG". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03610529. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*